Biomarker refers to objective indications of medical state, which can be measured accurately and reproducibly. Robust and validated biomarkers are required to understand the disease biology, improve diagnosis and clinical trials, and guide the development of targeted and safe therapies for various diseases. Our next generation sequencing (NGS), genotyping, and expertise delivers far more insight from biomarker genomics than traditional methods.
Benefits of Genomics in the Biomarker Field
Recent advances in NGS, microarray, and bioinformatics have accelerated biomarker discovery and profiling. Biomarker genomics allows researchers to generate sufficient data that span the human genome and simultaneously address a wide range of questions. Biomarker genomics consists of multiple methods, including DNA-, RNA-, and methylation-based profiling on a global scale or at target regions. It allows researchers to detect the known and novel biomarkers on a high-throughput and accurate manner and guide your decision making from drug discovery to the clinic. Biomarker genomics is also used in personalized medicine to predict medical diagnosis and treatment based on a patient’s genetic information.
Genomics Solutions in the Biomarker Field
Genomics Methods in the Biomarker Field
DNA methylation sequencing or microarray technologies serve to detect methylation sites in a high-throughput and accurate manner.
Tuesday, May 30, 2023
Jorge Bouças, PhD
Flaski – A Bioinformatics Tool for Data Analysis and VisualizationRegister Now